Search research articles
Contact Us
Filters
Showing results (31-40 of 52) with videos related to
Page
of 6
Sort By:
Clinical Oncology (Royal College of Radiologists (Great Britain))
|
November 27, 2021
Four-year Prostate-specific Antigen Response Rate as a Predictive Measure in Intermediate-risk Prostate Cancer Treated With Ablative Therapies: The SPRAT Analysis
R M Glicksman, A U Kishan, A J Katz, et al.
European Urology Open Science
|
May 31, 2022
Safety of Minimizing Intensity of Follow-up on Active Surveillance for Clinical Stage I Testicular Germ Cell Tumors
Peter J Gariscsak, Lynn Anson-Cartwright, Eshetu G Atenafu, et al.
Urologic Oncology
|
June 20, 2020
Use of combined androgen deprivation therapy with postoperative radiation treatment for prostate cancer: Impact of randomized trials on clinical practice
Noelia Sanmamed, Rachel M Glicksman, Jaime Herrera-Caceres, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
July 29, 2021
Elective pelvic nodal irradiation with a simultaneous hypofractionated integrated prostate boost for localized high risk prostate cancer: Long term results from a prospective clinical trial
Rachel M Glicksman, Andrew Loblaw, Gerard Morton, et al.
International Journal of Radiation Oncology, Biology, Physics
|
November 18, 2023
Randomized Trial of Concomitant Hypofractionated Intensity Modulated Radiation Therapy Boost Versus Conventionally Fractionated Intensity Modulated Radiation Therapy Boost for Localized High-Risk Prostate Cancer (pHART2-RCT)
Rachel M Glicksman, Andrew Loblaw, Gerard Morton, et al.
Clinical and Translational Radiation Oncology
|
September 25, 2024
Elective pelvic nodal irradiation in the setting of ultrahypofractionated versus moderately hypofractionated and conventionally fractionated radiotherapy for prostate cancer: Outcomes from 3 prospective clinical trials
Rachel M Glicksman, Andrew Loblaw, Gerard Morton, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
September 6, 2021
Elective nodal ultra hypofractionated radiation for prostate cancer: Safety and efficacy from four prospective clinical trials
Rachel M Glicksman, Stanley K Liu, Patrick Cheung, et al.
International Journal of Radiation Oncology, Biology, Physics
|
January 8, 2025
Clinical Outcomes of Stage IIA/IIB Seminoma Treated With Radiation Therapy and Chemotherapy: Should Regional Therapy be Considered the Preferred Treatment Approach?
Rachel M Glicksman, Di Maria Jiang, Philippe L Bedard, et al.
Neurology
|
February 20, 1999
HAART improves prognosis in HIV-associated progressive multifocal leukoencephalopathy
D B Clifford, C Yiannoutsos, M Glicksman, et al.
International Journal of Radiation Oncology, Biology, Physics
|
September 13, 2024
The Role of Stereotactic Body Radiotherapy in Oligoprogressive Malignant Disease (RADIANT): Oncologic Outcomes From a Phase 2 Nonrandomized Controlled Trial
Rachel M Glicksman, Srinivas Raman, Xiang Y Ye, et al.
Page
of 6
Search research articles
Search
Showing results (31-40 of 52) with videos related to
Sort By:
Page
of 6
Clinical Oncology (Royal College of Radiologists (Great Britain))
|
November 27, 2021
Four-year Prostate-specific Antigen Response Rate as a Predictive Measure in Intermediate-risk Prostate Cancer Treated With Ablative Therapies: The SPRAT Analysis
R M Glicksman, A U Kishan, A J Katz, et al.
European Urology Open Science
|
May 31, 2022
Safety of Minimizing Intensity of Follow-up on Active Surveillance for Clinical Stage I Testicular Germ Cell Tumors
Peter J Gariscsak, Lynn Anson-Cartwright, Eshetu G Atenafu, et al.
Urologic Oncology
|
June 20, 2020
Use of combined androgen deprivation therapy with postoperative radiation treatment for prostate cancer: Impact of randomized trials on clinical practice
Noelia Sanmamed, Rachel M Glicksman, Jaime Herrera-Caceres, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
July 29, 2021
Elective pelvic nodal irradiation with a simultaneous hypofractionated integrated prostate boost for localized high risk prostate cancer: Long term results from a prospective clinical trial
Rachel M Glicksman, Andrew Loblaw, Gerard Morton, et al.
International Journal of Radiation Oncology, Biology, Physics
|
November 18, 2023
Randomized Trial of Concomitant Hypofractionated Intensity Modulated Radiation Therapy Boost Versus Conventionally Fractionated Intensity Modulated Radiation Therapy Boost for Localized High-Risk Prostate Cancer (pHART2-RCT)
Rachel M Glicksman, Andrew Loblaw, Gerard Morton, et al.
Clinical and Translational Radiation Oncology
|
September 25, 2024
Elective pelvic nodal irradiation in the setting of ultrahypofractionated versus moderately hypofractionated and conventionally fractionated radiotherapy for prostate cancer: Outcomes from 3 prospective clinical trials
Rachel M Glicksman, Andrew Loblaw, Gerard Morton, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
September 6, 2021
Elective nodal ultra hypofractionated radiation for prostate cancer: Safety and efficacy from four prospective clinical trials
Rachel M Glicksman, Stanley K Liu, Patrick Cheung, et al.
International Journal of Radiation Oncology, Biology, Physics
|
January 8, 2025
Clinical Outcomes of Stage IIA/IIB Seminoma Treated With Radiation Therapy and Chemotherapy: Should Regional Therapy be Considered the Preferred Treatment Approach?
Rachel M Glicksman, Di Maria Jiang, Philippe L Bedard, et al.
Neurology
|
February 20, 1999
HAART improves prognosis in HIV-associated progressive multifocal leukoencephalopathy
D B Clifford, C Yiannoutsos, M Glicksman, et al.
International Journal of Radiation Oncology, Biology, Physics
|
September 13, 2024
The Role of Stereotactic Body Radiotherapy in Oligoprogressive Malignant Disease (RADIANT): Oncologic Outcomes From a Phase 2 Nonrandomized Controlled Trial
Rachel M Glicksman, Srinivas Raman, Xiang Y Ye, et al.
Page
of 6